A confidential FDA memo is creating controversy after an official said the COVID-19 vaccine may have played a role in the deaths of at least 10 children.
The adult 21-valent pneumococcal conjugate vaccine (V116) shows strong immune responses and tolerability in vaccine-naive at risk adults.
The addition of a new 300mg presentation allows for greater dosing flexibility to ease overall treatment burden and discomfort. The interchangeable biosimilar was originally approved in March 2025 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback